TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
CombiGene AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
5,616
|
25,255
|
81,960 |
Financial expenses |
5
|
2
|
0 |
Earnings before taxes |
-36,130
|
-5,824
|
20,446 |
EBITDA |
-36,445
|
-4,117
|
22,976 |
Total assets |
122,184
|
149,663
|
162,102 |
Current assets |
104,584
|
131,687
|
141,039 |
Current liabilities |
4,209
|
5,769
|
7,745 |
Equity capital |
117,975
|
143,894
|
154,357 |
- share capital |
1,003
|
936
|
965 |
Employees (average) |
8
|
10
|
8 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
96.6%
|
96.1%
|
95.2% |
Turnover per employee |
702
|
2,526
|
10,245 |
Profit as a percentage of turnover |
-643.3%
|
-23.1%
|
24.9% |
Return on assets (ROA) |
-29.6%
|
-3.9%
|
12.6% |
Current ratio |
2484.8%
|
2282.7%
|
1821.0% |
Return on equity (ROE) |
-30.6%
|
-4.0%
|
13.2% |
Change turnover |
-21,431
|
-54,241
|
81,960 |
Change turnover % |
-79%
|
-68% | |
Chg. No. of employees |
-2
|
2
|
4 |
Chg. No. of employees % |
-20%
|
25%
|
100% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.